ALK-Abelló (Denmark)

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for ALK-Abelló (Denmark), Denmark, covering academic research published from 2000 to 2024. Read More.

Open Access Percentage

44%

Total
Publications

849

Total Open
Publications

373

Total
Citations

32K

Open Access
Percentage

44%

Total
Publications

849

Total Open
Publications

373

Total
Citations

32K

Wikipedia

Website

download

Breakdown

Publisher Open

28%

Both

12%

Other Platform Open

Closed

57%

Percentage of Open Access over time

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

Open

Closed

Publisher Open

OA Journal 27%

Hybrid 17%

No Guarantees 56%

188

Other Platform Open

Domain 63%

Institution 39%

Other Internet 14%

Public 1%

Preprint 0%

Other Platform Locations

Name	Platform Type	Publications
PubMed Central	Domain	85
DOI	Other Internet	15
Site cant be reached	Institution	5
King's College London - Research Portal	Institution	5
Europe PMC	Domain	5
Unknown Repository	Other Internet	4
RISalud Institutional Health Repository of Andalucía	Institution	4
University of Ferrara - Institutional Research Information System University of Ferrara	Institution	3
Technical University Munich - mediaTUM – the media and publications repository of the Technical University Munich	Institution	3
Servicio Gallego de Salud (SERGAS - RUNA. Repositorio Institucional del Sergas)	Institution	3

1 / 5

Data updated 18 August 2025